Learn about our comprehensive antibody validation methods to ensure monospecificity. Antibody Validation>>
Formalin-fixed, paraffin-embedded human Colon Carcinoma stained with BMI1-Monospecific Mouse Monoclonal Antibody (BMI1/2689).
Formalin-fixed, paraffin-embedded human Colon Carcinoma stained with BMI1-Monospecific Mouse Monoclonal Antibody (BMI1/2689).
Western Blot Analysis of Human 293T cell lysate using BMI1-Monospecific Mouse Monoclonal Antibody (BMI1/2689).
SDS-PAGE Analysis of Purified BMI1-Monospecific Mouse Monoclonal Antibody (BMI1/2689). Confirmation of Purity and Integrity of Antibody.
Analysis of Protein Array containing more than 19,000 full-length human proteins using BMI1-Monospecific Mouse Monoclonal Antibody (BMI1/2689) Z- and S- Score: The Z-score represents the strength of a signal that a monoclonal antibody (MAb) (in combination with a fluorescently-tagged anti-IgG secondary antibody) produces when binding to a particular protein on the HuProtTM array. Z-scores are described in units of standard deviations (SD's) above the mean value of all signals generated on that array. If targets on HuProtTM are arranged in descending order of the Z-score, the S-score is the difference (also in units of SD's) between the Z-score. S-score therefore represents the relative target specificity of a MAb to its intended target. A MAb is considered to specific to its intended target, if the MAb has an S-score of at least 2.5. For example, if a MAb binds to protein X with a Z-score of 43 and to protein Y with a Z-score of 14, then the S-score for the binding of that MAb to protein X is equal to 29.
The B cell-specific moloney murine leukemia virus integration site 1 (Bmi-1) is a transcriptional receptor of the polycomb gene family involved in several cellular processes including cell-cycle regulation, apoptosis, and maintenance of adult and neoplastic stem cells by providing self-renewal capacity. Further, Bmi-1 expression has been associated with malignant transformation, tumor progression, metastatic disease, and poor prognosis in human malignancies.
There are no reviews yet.